Recruiting Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors NCT06943755 Conditions Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +19 more Locations The University of Alabama at Birmingham — Birmingham, Alabama, United States Mayo Clinic Hospital — Phoenix, Arizona, United States The University of Arizona Cancer Center — Tucson, Arizona, United States Cedars-Sinai Medical Center — Beverly Hills, California, United States View all 117 locations View more locations Show fewer locations Loading locations... View Trial Details
